IQVIA Holdings Inc. IQV

Company Overview

IQVIA Holdings Inc. (IQV) is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, including pharmaceutical, biotechnology, medical device, and healthcare stakeholders. The company operates at the intersection of healthcare data, technology, and scientific expertise, supporting the development, commercialization, and optimization of medical treatments across the product lifecycle.

IQVIA’s primary revenue drivers are its Technology & Analytics Solutions and Research & Development Solutions segments, which together deliver data-driven insights, real-world evidence, clinical trial execution, and commercial analytics. The company serves large and mid-sized pharmaceutical companies, emerging biotech firms, contract research organizations, healthcare providers, and regulators. IQVIA’s strategic advantage lies in its scale of proprietary healthcare data, integrated analytics platforms, and global clinical trial infrastructure. The company was formed in 2016 through the merger of IMS Health and Quintiles, combining commercial healthcare intelligence with clinical research capabilities into a single integrated platform.